Two and a half years. That's how long it took Galaxea AI, a robotics startup born in a Beijing co-working space in September 2023, to cross the $1 billion valuation threshold. The company announced its Series B on February 11, pulling in 1 billion yuan—about $144 million—and cementing a post-money valuation of roughly 10 billion yuan.
If that timeline feels compressed, it is. Galaxea has now raised close to 3 billion yuan (nearly $420 million) since its founding, a pace that reflects both investor appetite for embodied intelligence and the mounting pressure to claim territory before the window closes. Or perhaps it reflects something else: a belief that whoever masters the marriage of software brains and physical limbs first will own a market Beijing has declared strategically vital.
The latest round drew a sprawling coalition—Jinding Capital, BAIC Group Industrial Investment, Hone Capital, Bihong Investment, Loyal Valley Capital, and Qianhai Ark all came in fresh. Existing backers didn't blink. Cathay Capital, Meituan DragonBall, Capital Today, Xianghe Capital, and GL Ventures all doubled down, according to Caixin Global. That kind of insider confidence usually means one of two things: either the product is working, or the fear of missing out has reached terminal velocity.
A Funding Blitz That Defies Convention
Galaxea's capital story reads less like careful stages and more like a relay race. Founded by a trio of ex-Waymo and Momenta engineers—CEO Gao Jiyang, a USC-trained computer vision specialist, alongside co-chief science officers Xu Huazhe (Berkeley PhD, Stanford postdoc, now Tsinghua faculty) and Zhao Hang (another Waymo alum)—the company moved fast.
Pre-A in November 2024: over 200 million yuan, led by GL Ventures and Ant Group. Series A in February 2025: nearly 300 million yuan. Then things got interesting. A2 and A3 tranches in April 2025, exceeding 300 million yuan combined, Cathay Capital leading. Dual strategic rounds in July 2025, more than $100 million, Capital Today and Meituan DragonBall fronting the charge. By August, Forbes had the valuation hovering around $700 million.
Seven months later, the Series B lands. The cadence is unusual, even for China's hyperactive venture scene. It suggests either extraordinary traction or a land-grab mentality among backers eager to lock in exposure before the sector consolidates. COO Li Tianwei, formerly a senior director at Momenta, hasn't commented publicly on burn rate or profitability targets.
One Brain, Many Bodies
Galaxea pitches itself around a phrase that sounds like marketing but carries real technical weight: "one brain, multiple morphologies." The idea is to build vision-language-action (VLA) foundation models—essentially AI that can see, understand language, and manipulate objects—then deploy those models across different physical forms.
The hardware lineup includes the R1 Pro, a seven-degree-of-freedom dual-arm wheeled platform, and the R1 Lite, a six-DOF variant priced at $39,999. There's also the A1 X, a desktop arm aimed at researchers, and a suite of VLA developer tools. In January 2026, the company released G0 Plus, an "out-of-the-box" embodied model that Galaxea claims has been downloaded more than 500,000 times from open-world datasets. The R1 Pro also serves as the reference hardware for Ant Group's open-source LingBot-VLA model, a collaboration that may be strategic positioning as much as technical partnership.
Galaxea says it has thousands of units on order across universities, research labs, and industry partners globally. The company previously set a goal of shipping up to 1,000 units by late 2025, split between domestic and international markets, though it hasn't confirmed whether that target was met.
Racing in a Crowded, Frothy Field
Galaxea's unicorn moment arrives during what can only be described as a financing frenzy. Rival Unitree Robotics hit a roughly 12 billion yuan valuation in mid-2025 and is reportedly eyeing a pre-IPO round. Galbot, another Beijing-based contender, raised more than $300 million in December 2025 at a 30 billion yuan valuation—a figure that raised eyebrows even among venture insiders.
Beijing has elevated embodied intelligence to a national priority, folding it into industrial policy documents and funding roadmaps. But enthusiasm has collided with caution. In early 2026, Chinese regulators floated concerns about a potential humanoid robotics "bubble," language that typically precedes tighter scrutiny or funding slowdowns. Whether that's prescient or premature depends on whom you ask.
Galaxea hasn't disclosed how it plans to deploy the fresh capital. The company could plow it into hardware scaling, model training, international expansion, or simply extend its runway while the sector sorts itself out. For now, the unicorn badge matters less than what comes next: proving that robots trained on massive datasets can actually do useful work outside the lab. That's the bet investors are making. And at this pace, they won't have to wait long for an answer.
